Preview

October 2019

In the next issue of Pharma Technology Focus we take a look back at the ways that viruses have been used to fight diseases, speak to Paris-based biotech company SparingVision to discuss the future of specialist eye interventions, and explore the potential of an advanced smart pill bottle designed to improve patient adherence.


Also, we find out how the WHO’s essential medicines list is compiled and its commercial significance for the pharma industry, examine why pharma is starting to move away from animal testing and the alternative options being developed and implemented, and analyse why pharma is so bad at sharing clinical trial information.


Plus, we learn about the trials of building the world’s first and largest pan-African biobank from new enterprise 54gene and explore whether Netflix-style subscription payment models for drugs are a good idea.

EDITORIAL

Editor | Eloise McLennan

Group Editor | Susanne Hauner

Commissioning Editor| Daniel Garrun

Writers | Allie Nawrat, Abi Millar, Chris Lo, Siniša Belina, Agnes Cwienczek
Magazine Designer | Marzia Del Gaone

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Filipe Costa
Lead Designer | John Hammond 
Digital Publishing Director | Duncan West

Advertising

Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Marketing

For media partnership enquiries please contact our publishing assistant: Sophie Hoare

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Pharma Technology Focus is a product of Net Resources International. Copyright 2019 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.

Go to article: Home | A new era of buyers clubsGo to article: TSS ABGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Capsugel Company InsightGo to article: The pharma industry briefingGo to article: ICCI Company InsightGo to article: ICCIGo to article: Corbion PuracGo to article: Real world data: improving clinical trial outcomesGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Understanding allergic reactions: chronicling the work of Dr Teruko IshizakaGo to article: Scandinavian HealthGo to article: Moehs Iberica SLGo to article: Swiss WorldCargoGo to article: Buyers’ clubs: the first step toward universal UK access to Orkambi?Go to article: TSS Company InsightGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Prescription dread: measuring psychiatric drugs against the alternativesGo to article: BEAGo to article: ZenatekGo to article: PfanstiehlGo to article: Herd health: agriculture’s role in the global AMR crisisGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Hapa Company InsightGo to article: ConcePTION: tackling the unknowns of medication in pregnancyGo to article: AEB Company Insight Go to article: AEBGo to article: Pfeiffer VacuumGo to article: From start-ups to the SIX Swiss Exchange – a Swiss success storyGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Cancer drug discovery: unravelling the mysteries of halichondrinGo to article: Centaur Clinical | Company InsightGo to article: IDMP is back: what next?Go to article: Charles Ischi Go to article: Adhesives ResearchGo to article: Emirates SkyCargoGo to article: Global labelling management: why does it continue to cause problems?Go to article: B&W TekGo to article: EventsGo to article: Dali Medical devicesGo to article: Spirax Sarco Company InsightGo to article: Spirax SarcoGo to article: Centaur ClinicalGo to article: Next issueGo to article: AralabGo to article: Baxter